InterSystems Targets RHIO Market with HealthShare


By Cindy Atoji

May 27, 2008 | Despite their struggles to find a solid business model, RHIOs and HIEs are becoming strong markets for health IT. Recently, InterSystems, a Cambridge, Mass.-based integration platform supplier, has had success selling its HealthShare product as the backbone for RHIOs in central Florida, Rhode Island, and New York. HealthShare leverages InterSystem’s Ensemble, an integration tool suite, and CACHE, a database. Paul Grabscheid, VP of strategic planning, spoke with Digital HealthCare & Productivity about the move to connectivity among health care providers and the challenges it poses.

DHP: What are the major challenges health care providers must overcome as they try to move to a more connected environment?

Grabscheid: Many health care organizations offering a variety of medical programs take a “best of breed” approach when implementing software. This often results in a loosely coupled network of administrative, financial, clinical, and logistical applications, each one using different technologies, databases, hardware platforms, and operating systems. As the systems get more imbedded in organization, it gets harder to take them out—it’s too expensive and time consuming to make a change.

One of the things we see people focusing on today is that rather than ripping out and replacing systems, they’re focusing more on building connectivity between systems. Organizations want to put together an integrated system that will support a variety of solutions for electronic medical records, data warehouses, physician portals, executive dashboards, regulatory compliance, and more. That’s why maintaining flexibility is key. From a technology standpoint, you want to have service orientated architecture (SOA) and think about the functions that the system provides and how, in some modular way, you can make talk to each other.

DHP: Do you have advice for managing these kinds of projects?

Grabscheid: You can’t view these just as technology projects. If you don’t get clinician involvement and buy-in early in the process, you’re going to fail. We’re often prone to look at integration as a technology problem and build things which are technically elegant, but not very useful or usable for the population.

DHP: What is the potential ROI for connecting and integrating systems?

Grabscheid: The ROI comes in a couple of buckets. The most measurable ROI comes from making information more available and eliminating duplicate tests. That’s the easiest saving to quantify: If you had access to all your recent lab tests, you wouldn’t have to order tests again. Second is avoiding adverse events. If I can connect to your information and understand you’re allergic to penicillin, I can avoid giving you something you shouldn’t have. And in some cases when communities start getting connected, they’re distributing information they were already distributing, but now doing it in a more efficient way. So they’re taking lab results that used to go out by fax and doing it at lower price electronically. But it’s hard to cost-justify a lot of these community or regional projects.

DHP: How are health care providers addressing patient concerns about privacy and security as more clinicians and administrators gain access to their EHRs?

Grabscheid: This is a theme I see all the time: people are concerned about security and privacy. One of the challenges that comes from connecting things together is making sure connections aren’t abused and you’re not creating an environment where the weakest link exposes everyone to misuse of information. You have to be attentive, maybe even paranoid about those issues.

Then you also get into specific issues, such as, how do I get consent form patient, and what’s the nature of that consent. People have different ideas—medical and legal—about what kinds of rules make sense for granting consent and disclosure of info. And when you have a bunch of people thinking about a problem, they can come up with a complicated solution. You need something that fits on one side of a sheet of paper on clipboard that the receptionist can hand to you when you walk into the doctor’s office. We try to tell people, “keep the clipboard test in mind.”

DHP: A lot has been written about the difficulties of sustainability when it comes to RHIOs in the U.S. What’s your perspective on the future of RHIOs?

Grabscheid: The idea of connecting together at the regional level is vital, but I’m not convinced we’ve figured out how to do it from an economic and organizational perspective. My guess is, five years from now, none of us will know what those four letters, RHIO, stood for—things will have morphed again. But it is inevitable that health care gets connected at the regional level.

______________________

Sign up for a free subscription to Digital HealthCare & Productivity.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports


Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
sponsored by SAS

Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process
    Download now


Addressing Life Sciences Constantly Growing Data Challenges Research Environments
Sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency. Download now


“Storage for Science – Methods for Managing Large and Rapidly Growing Data Stores in Life Science Research Environments” sponsored by Isilon
Large and rapidly growing stores of file-based and other data are a hallmark of life science research and bioinformatics. Determining how best to manage those data stores has become a significant challenge for Researchers and IT Pros alike.

This paper is intended to:

  • Provide guidance on the many storage requirements common to Life Science research;
  • Explain the evolution of modern storage architectures;
  • Summarize the major data storage architectures currently in use.

Additionally, it will present the Isilon IQ clustered storage product as a strong and flexible solution to those needs. Download now



Life Science Webcasts & Podcasts

Storage for Science
Methods for Managing Large and Rapidly Growing Data Stores in Life Science Research Environments

Sponsored by Isilon

Large and rapidly growing stores of file-based and other data are a hallmark of life science research and bioinformatics environments. Determining how best to manage those data stores has become a significant challenge for the Researchers and IT Professionals that support them.

This webcast is intended to:

  • Provide guidance on the many storage requirements common to Life Science research;
  • Explain the evolution of modern data storage architectures;
  • Summarize the major data storage architectures currently in use;
  • Present the Isilon IQ clustered storage product as a strong and flexible solution to those needs.

    Download this webcast

More Podcasts

Job Openings

Merck ~Sr. Computational Biologist
Apply and develop computational biology/informatics techniques to support Oncology drug discovery; collaborate with scientists to develop in-depth understanding of deregulated signaling pathways, discover novel targets and treatment strategies, and identify associated candidate biomarkers. Ph.D. in Computational Biology/Bioinformatics, solid statistics background and hands-on modeling and informatics techniques related to drug discovery experience required. Click to Apply

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD

Related Resources & Products

Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
Targeted Immunotherapeutics and Vaccines
Targeted Immunotherapeutics and Vaccines



For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125 or via email to [email protected].